Attitude toward PG:
The mean (±SD) total attitude score was 21.18 (±2.58) out of 24. The vast majority of respondents had a positive attitude on all surveyed attitude items. For instance, approximately 77% of respondents agreed that PG testing will help to improve drug efficacy, 72% believed that it will help to decrease the time it takes to find the optimal dose of a drug, and almost 77% agreed that it will enable them to effectively control drug therapy expenditures. Encouragingly, 64.2% of our sample expressed interest in attending training sessions or workshops on PG in the future.
Moreover, there were no significant differences in mean total attitude score based on gender (p=0.13), age groups (p= 0.19), or primary work settings (p= 0.35). However, stratifying respondents according to seniority levels showed a significant difference in mean total attitude score, as the specialist physicians were found to have a higher mean attitude score (21.69 ± 2.54) compared to residents (20.57 ± 2.65;p=0.03 ), as detailed in Table 2.